行业产品

  • 行业产品

上海博研生物工程研究中心


当前位置:上海博研生物工程研究中心>>科研抗体>>抗体>>Anti-CCL4/MIP-1 Beta抗体,巨噬细胞炎性蛋白1β抗体-产品说明

Anti-CCL4/MIP-1 Beta抗体,巨噬细胞炎性蛋白1β抗体-产品说明

返回列表页
参  考  价面议
具体成交价以合同协议为准

产品型号

品       牌

厂商性质代理商

所  在  地上海市

更新时间:2018-05-18 19:40:30浏览次数:227次

联系我时,请告知来自 环保在线

经营模式:代理商

商铺产品:9977条

所在地区:上海上海市

联系人:杨洋 (经理)

产品简介

博研生物强烈*“Anti-CCL4/MIP-1 Beta抗体,巨噬细胞炎性蛋白1β抗体-产品说明",品质保障,*,提供,实验无结果可免费退换!:

详细介绍

产品名称:Anti-CCL4/MIP-1 Beta抗体,巨噬细胞炎性蛋白1β抗体-产品说明

产品编号:BYK-2475R

产品规格:0.1ml/0.2ml

产品价格:请

英文名称 CCL4
中文名称 巨噬细胞炎性蛋白1β抗体
别    名 MIP-1 Beta; Macrophage Inflammatory Protein 1 beta; MIP-1 Beta; MIP-1β; Secreted protein G 26; ACT 2; ACT2; AT744.1; CC chemokine ligand 4; CCL4; ccl4l 1; CCL4L1; Chemokine CC Motif Ligand 4; G 26 T lymphocyte secreted protein; HC21; LAG 1; LAG1; Lymphocyte activation gene 1; Lymphocyte activation gene 1 protein; Macrophage inflammatory protein 1 beta; MGC104418; MGC126025; MGC126026; MIP1 beta; MIP1B; MIP1B1; PAT 744; Protein H400; SCYA2; SCYA4; Secreted protein G26; SIS gamma; Small inducible cytokine A4; T cell activation protein 2; CCL4_MOUSE;
研究领域 肿瘤  细胞生物  免疫学  转录调节因子  

抗体来源:本公司抗体有兔来源和鼠来源等

克隆类型:兔来源为多抗,鼠来源为单抗

产品类型:一抗

此抗体本公司有单抗和多抗,可用于免疫组化(IHC),免疫印迹(WB),酶联免疫(ELISA),IF、IP、流式细胞术等实验(可来电索取说明)

此产品本公司有标记的一抗出售,相关标记有:Alexa Fluor 350 标记、Alexa Fluor 488 标记、Alexa Fluor 555 标记、Alexa Fluor 647 标记、AP标记、APC标记、Biotin标记、Cy3标记、Cy5标记、Cy5.5标记、Cy7标记、FITC标记、Gold标记、HRP标记、PE标记、PE-Cy3标记、PE-CY5标记、PE-CY5.5标记、PE-CY7标记、RBITC标记


Anti-CCL4/MIP-1 Beta抗体,巨噬细胞炎性蛋白1β抗体-产品说明产品介绍:MIP1 alpha and MIP1 beta were originally co-purified from medium conditioned by an LPS-stimulated murine macrophage cell line. Human MIP1 beta refers to the products of several independently cloned cDNAs, including Act2, PAT 744, hH400, G26, HIMAP, HC21, and MAD 5a. The predicted protein products of these cDNAs represent variants that are between 94% - 98% identical and these proteins are all approximay 75% homologous to murine MIP1 beta. MIP1 beta also shares approximay 70% amino acid identity with MIP1 alpha. MIP1 proteins are expressed primarily in T cells, B cells, and monocytes after antigen or mitogen stimulation. The MIP1 proteins have chemoattractant and adhesive effects on lymphocytes, with MIP1 alpha and MIP1 beta preferentially attracting CD8+ and CD4+ T cells, respectively. A signal transducing receptor designated the CC chemokine receptor 1 (CC CKR1) with seven transmembrane domains that binds MIP1 alpha, MIP1 beta, MCP1 and RANTES with varying affinities has been isolated.

性    状 Lyophilized or Liquid
浓    度 1mg/1ml
亚    型 IgG
纯化方法 affinity purified by Protein A
储 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

保存条件:  Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The  lyophilized antibody is stable at room temperature for at least one month and for greater  than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent  of antibody, the antibody is stable for at least six weeks at 2-4 ℃


优势产品:

Anti-ADAM-TS12/FITC  荧光素标记整合素样金属蛋白酶与*1型-12抗体IgG
Anti-ACV-A/FITC  荧光素标记活化素A抗体IgG
Anti-Adducin protein/FITC  荧光素标记内收蛋白抗体IgG
Anti-Adenosine A2A-R/FITC  荧光素标记腺苷A2A受体抗体IgG
Anti-ADFP/ADRP/adipophilin/FITC  荧光素标记脂肪组织分化相关蛋白抗体IgG
Anti-ADH/AVP/FITC   荧光素标记抗利尿激素/血管升压素抗体IgG
Anti-Adipo R1/FITC  荧光素标记脂联素受体-1蛋白抗体IgG
Anti-Adipo R2 /FITC  荧光素标记脂联素受体-2抗体IgG
Anti-Adiponectin/FITC  荧光素标记脂联素抗体IgG
Anti-ADM/FITC  荧光素标记肾上腺髓质素抗体IgG
Anti-ADM R/FITC  荧光素标记肾上腺髓质素受体抗体IgG
Anti-ADMR/FITC  荧光素标记肾上腺髓质素受体抗体IgG
Anti-ADNP/FITC  荧光素标记活性依赖的神经保护肽抗体IgG
Anti-ADO/FITC  荧光素标记2-氨基乙硫醇双加氧酶抗体IgG
Anti-ADORA3/A3AR /FITC  荧光素标记腺苷受体A3抗体IgG
Anti-ADRA2/FITC  荧光素标记alpha-2肾上腺素能受体抗体IgG
Anti-ADRB1/FITC  荧光素标记肾上腺素能受体β1抗体IgG
Anti-ADRB2/FITC  荧光素标记肾上腺素能受体β2抗体IgG
Anti-ADRB2/RBITC  罗丹明标记肾上腺素能受体β2抗体IgG
Anti-ADRB3/β3-AR /RBITC  罗丹明标记肾上腺素能受体β3抗体IgG

其他推荐产品更多>>

感兴趣的产品PRODUCTS YOU ARE INTERESTED IN

环保在线 设计制作,未经允许翻录必究 .      Copyright(C) 2021 https://www.hbzhan.com,All rights reserved.

以上信息由企业自行提供,信息内容的真实性、准确性和合法性由相关企业负责,环保在线对此不承担任何保证责任。 温馨提示:为规避购买风险,建议您在购买产品前务必确认供应商资质及产品质量。

会员登录

×

请输入账号

请输入密码

=

请输验证码

收藏该商铺

登录 后再收藏

提示

您的留言已提交成功!我们将在第一时间回复您~